Inspire Corporate Bond ETF
Limited financial coverage for IBD.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
The Inspire Corporate Bond ETF primarily invests in high-quality debt securities issued by large American corporations that are selected for their inspiring and biblically aligned principles. This fund aims to mirror the performance outcomes of the Inspire Corporate Bond Index.
- IPO
- 2017
- HQ
- Wheaton, IL, US
Get TickerSpark's AI analysis on IBD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $465.65M
- Div Yield
- 4.35%
- 52W High
- $24.78
- 52W Low
- $22.50
- 50D MA
- $23.43
- 200D MA
- $23.81
- Beta
- 0.66
- RSI (14)
- 46
- Avg Volume
- 78.30K
No earnings-call transcripts are available for IBD yet.
- Free Float
- 0.0%
- Shares Outstanding
- 20.10M
- Float Shares
- 0
of shares held by institutions
111 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Inspire Advisors, LLC | 4.10M | ▼ 225.33K |
| Ambassador Advisors, LLC | 1.72M | ▲ 54.20K |
| Creative Financial Designs Inc /Adv | 968.28K | ▼ 88.20K |
| Lpl Financial LLC | 823.29K | ▲ 207.80K |
| Bare Financial Services, Inc | 795.09K | ▲ 25.21K |
| Inspire Investing, LLC | 768.59K | ▼ 220.13K |
| Oneascent Financial Services LLC | 548.88K | ▼ 115.05K |
| Plan A Wealth LLC | 395.82K | ▲ 73.78K |
| Pax Financial Group, LLC | 348.67K | ▲ 4.67K |
| United Capital Financial Advisers, LLC | 267.45K | ▲ 41.53K |
| Assetmark, Inc | 222.97K | ▲ 10.89K |
| Lvz, Inc. | 197.63K | ▲ 2.33K |
Our IBD coverage
Recent articles, reports, and earnings notes.
No research on IBD yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IBD report →Spyre: Maintain 'Strong Buy' On Additional SPY072 Shots On Goal Q4 2026 And IBD Combination Potential
seekingalpha.com · Oct 7
AI-Fueled Precision Oncology Firm Guardant Health Is In Focus. Here's Why.
investors.com · Sep 21
Spyre Announces Potential Best-in-Class SPY003 (anti-IL-23) Part A Induction Results from SKYLINE Trial, Completing Proof-of-Concept for All Three Components of its IBD Combinations
globenewswire.com · Sep 8
Inspire Corporate Bond Fund (IBD) Receives 5-star Overall Morningstar Rating™ Among 155 Corporate Bond Funds
prnewswire.com · Aug 25
Can Spyre's SPY772 HS Study Broaden Its Growth Story Beyond Core IBD?
zacks.com · Aug 24
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now?
zacks.com · Aug 10
Beyond The Megacaps: What To Watch In Eli Lilly, Sandisk, SpaceX Earnings | IBD
youtube.com · Jul 31
Palisade Bio Draws Bullish Call, Lead IBD Drug Advances Toward Phase 2
benzinga.com · Jul 23
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.